Replies to post #111217 on Biotech Values

[dewophile]

ABT agrees with you:

http://www.clinicaltrials.gov/ct2/show/NCT01221298?term=abbott+hepatitis+c&rank=2

they have entered the fray with an all oral combo very similar to VRTX - PI (with booster) plus non-nuke plus rib sans interferon. notably absent is any treatment arm containing interferon (the design is open label which imo is smart to save money recruiting a positive control before you even know if DAAs + rib without interferon is a viable combination)